Mindfulness-Based Psychoeducation for Women With Gynecological Cancer
ConditionGynecologic Cancers
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorOndokuz Mayıs University
About this trial
This randomized controlled study aims to evaluate the effect of a mindfulness-based psychoeducation program on hope, cognitive-emotional coping with cancer, quality of life, and psychological well-being in women diagnosed with gynecological cancer. Women receiving treatment for gynecological cancer will be randomly assigned to either an intervention group and a control group. The intervention group will participate in an 8-week mindfulness-based psychoeducation program delivered in small groups via online platforms under the guidance of the researcher. The program will include mindfulness practices such as breathing exercises, body scan, awareness exercises, and guided imagery techniques aimed at improving emotional coping and psychological well-being. The control group will receive usual care. Outcomes will be assessed at baseline, immediately after the intervention, and at 3- and 6-month follow-up assessments.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Women who voluntarily agree to participate in the study
Women aged 18 years and older
Women diagnosed with gynecological cancer and currently undergoing active treatment (e.g., surgery, chemotherapy, radiotherapy, immunotherapy, or targeted therapy)
Ability to participate in online sessions from home after hospital discharge
Disqualifiers
Diagnosis of a psychiatric disorder that may interfere with participation
Current use of psychiatric medications
Previous participation in Mindfulness-Based Stress Reduction (MBSR) or similar mindfulness programs
Having a physical condition that prevents participation in the intervention sessions
Trial design
Design model
Parallel
Treatments tested in this trial
Mindfulness-Based Psychoeducation Program
BehavioralThe mindfulness-based psychoeducation program is designed to support psychological well-being and coping with cancer among women diagnosed with gynecological cancer. The program consists of eight weekly sessions conducted in small groups of approximately 4-5 participants and delivered through online platforms under the guidance of the researcher. The sessions include mindfulness-based practices such as breathing exercises, body scan meditation, awareness exercises, guided imagery, and reflective group discussions. The program aims to enhance participants' awareness of the present moment, improve emotional regulation, strengthen coping with cancer, and promote psychological well-being, hope, and quality of life.
Usual Care
BehavioralParticipants in the control group will receive usual care provided by the healthcare institution and will not participate in the mindfulness-based psychoeducation program during the study period.
Treatment groups
96 Participants
are divided into 2 treatment groupsGroup A: Mindfulness-Based PsychoeducationExperimental treatment 1 intervention
Group B: Usual CareOther 1 intervention
Trial outcomes
Primary outcomes
1
Hopelessness Measured by Beck Hopelessness Scale
Hopelessness will be assessed using the Beck Hopelessness Scale (BHS). The scale measures negative expectations about the future and pessimistic attitudes. Higher scores indicate greater levels of hopelessness among participants.
Time frame
Baseline, immediately after the intervention, 3 months, and 6 months follow-up2
Cognitive-Emotional Coping with Cancer Scale Scores
Cognitive-emotional coping with cancer will be assessed using the Cognitive-Emotional Coping with Cancer Scale. Higher scores indicate more adaptive coping strategies among women diagnosed with gynecological cancer.
Time frame
Baseline, immediately after the intervention, 3 months, and 6 months follow-up3
Quality of Life Measured by EORTC QLQ-C30
Quality of life will be assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). Higher scores on functional scales indicate better quality of life among women diagnosed with gynecological cancer.
Time frame
Baseline, immediately after the 8-week intervention, 3 months, and 6 months after the intervention4
Psychological Well-Being Measured by the Psychological Well-Being Scale
Psychological well-being will be assessed using the Psychological Well-Being Scale. Higher scores indicate better psychological well-being among women diagnosed with gynecological cancer.
Time frame
Baseline, immediately after the 8-week intervention, 3 months, and 6 months after the interventionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: